Related Experiment Video
Updated: Sep 16, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Regulation and signaling of SNX10, a tumor suppressor in hepatocellular carcinoma
Lidia C Diaz-Fernandez1, Carolina Piña-Vázquez1, Hury V Hernandez-Galdamez1
1Center for Research and Advanced Studies of the National Polytechnic Institute, Department of Cell Biology. Mexico City, Mexico.
Abstract:
SNX10 is a protein belonging to the "Sorting Nexin" family, characterized by the presence of the PX phosphoinositide binding domain. SNX10 is involved in endosomal regulation and may act as a tumor suppressor in cancer, as it is underexpressed in a rat model of chemical hepatocarcinogenesis and in colon cancer. In colorectal carcinoma, SNX10 serves as a negative regulator of chaperone-mediated autophagy (CMA). However, recent studies have also indicated its pro-oncogenic properties in cancer development. In this study, we investigated the role of SNX10 in hepatocellular carcinoma (HCC), the cancer type responsible for the third highest number of cancer deaths worldwide. Our findings revealed that SNX10 expression is lower in HCC tumors than in healthy tissue in both patients and an animal model. Moreover, SNX10 expression is markedly reduced in HCC cell lines with mesenchymal traits when compared with epithelial traits cells, suggesting that decreased SNX10 expression is associated with disease progression. SNX10 negatively regulates LAMP2A and consequently CMA but positively regulates the CMA target proteins p21 and IκBα in HCC cells. It also downregulates AFP, BCL-2, and DKK1 transcription. Additionally, miR-30d and SNX10 exhibit an inverse relationship in HCC cells, with miR-30d identified as a negative regulator of SNX10 in this context. Through these mechanisms, SNX10 functions as a tumor suppressor by inhibiting proliferation, migration, invasion, and tumorigenesis of HCC.
Insights
Sorting Nexin 10 (SNX10) acts as a tumor suppressor in hepatocellular carcinoma (HCC). Lower SNX10 expression correlates with HCC progression and reduced patient survival, inhibiting cancer growth and spread.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Sorting Nexin 10 (SNX10), a PX domain-containing protein, is implicated in endosomal regulation.
- SNX10's role in cancer is debated, with evidence suggesting both tumor-suppressive and oncogenic functions.
- Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally, necessitating research into its underlying mechanisms.
Purpose of the Study:
- To investigate the role of SNX10 in hepatocellular carcinoma (HCC) pathogenesis.
- To determine the relationship between SNX10 expression levels and HCC progression.
- To elucidate the molecular mechanisms by which SNX10 influences HCC development.
Main Methods:
- Analysis of SNX10 expression in HCC patient tissues and animal models.
- Comparison of SNX10 expression in HCC cell lines with varying mesenchymal and epithelial traits.
- Investigation of SNX10's regulatory effects on chaperone-mediated autophagy (CMA) components (LAMP2A) and target proteins (p21, IκBα).
- Assessment of SNX10's impact on the transcription of key HCC-associated genes (AFP, BCL-2, DKK1).
- Examination of the regulatory relationship between miR-30d and SNX10 in HCC cells.
Main Results:
- SNX10 expression was significantly lower in HCC tumors compared to healthy tissues and correlated with disease progression.
- Reduced SNX10 expression was observed in HCC cell lines with mesenchymal characteristics.
- SNX10 negatively regulated LAMP2A and CMA, while positively affecting p21 and IκBα levels.
- SNX10 downregulated the transcription of AFP, BCL-2, and DKK1.
- An inverse relationship between miR-30d and SNX10 was identified, with miR-30d acting as a negative regulator of SNX10.
Conclusions:
- SNX10 functions as a tumor suppressor in HCC by inhibiting proliferation, migration, invasion, and tumorigenesis.
- Decreased SNX10 expression is associated with HCC progression and potentially poorer outcomes.
- The miR-30d/SNX10 axis represents a novel regulatory pathway in HCC development.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway